Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 6 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. Case report and literature review: histologic transformation from EGFR-mutant lung adenocarcinoma to squamous cell carcinoma with newly detected SMAD4 and ATM variants
    Chao Wang, Shuo Wang, Daixi Wu +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  2. A study on the temporal network characteristics of early post-chemotherapy core symptoms in colorectal cancer patients based on ecological momentary assessment
    Yuanfeng Lv, Longke Xu, Minxiang Li +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  3. Exploring the potential mechanism of artemisinin against gastric cancer based on network pharmacology, machine learning and experimental validation
    Chenchen Hu, Yu Zhao, Minghui Yun +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  4. Early-onset breast cancer in two Brazilian tertiary cancer centers: a real-world study of years of life lost and clinical outcomes
    Diego Lopes Paim Miranda, Douglas Dias e Silva, Beatriz Viesser Miyamura +11
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  5. Case Report: Cerebellopontine angle metastatic adenocarcinoma with high-grade fetal morphology and no identifiable pulmonary primary on initial CT
    Xiaowen Liu, Chengxin Yan
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  6. Lynch syndrome associated with the pathogenic MSH2 p.A230Lfs*16 variant presenting with sequential colorectal, endometrial, and ampullary cancers: a case report
    Yu Hei, Zhaoshuai Ji, Lijun Jiao +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  7. Case Report: Cholestatic liver injury during atezolizumab therapy in EGFR-mutant combined small cell lung cancer with possible underlying primary biliary cholangitis
    Yingqiong Zhu, Jin Xiong, Chuan Tan +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  8. Clinical characteristics and prognosis analysis of secondary intestinal diffuse large B-cell lymphoma: a multi-center retrospective study over a decade
    Xiaojun Chen, Zhimin Yan, Jianzhen Shen +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  9. Association between platelet-to-white blood cell ratio and short-term prognosis in patients with acute myocardial infarction: a retrospective cohort study
    Zelin Kang, Yongxin Liao, Chong Zheng +3
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textOncologyCrossref
  10. Clinical, Biochemical, and Kidney Abnormalities in McKittrick–Wheelock Syndrome: An Individual-Patient Systematic Review of Published Cases
    Matilde Lepori, Virginia Turner, Massimiliano Bertacchi +7
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0OncologyCrossref
  11. Circulating Tumor DNA Across the Patient Journey in Pancreatic Cancer: From Molecular Profiling to Dynamic Disease Monitoring
    Makoto Abue, Naoki Asano, Takanori Morikawa +3
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  12. Real-World Treatment Patterns and Sequencing of ALK-Inhibitors in ALK-Positive NSCLC Treated with Palliative Intent
    Leyla Ay, Julie Krainer-Jacobs, Anna Lang-Stöberl +8
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  13. Chemotherapy Use, Healthcare Resource Utilisation, and Direct Costs in High-Risk Early-Stage ER+/HER2– Breast Cancer in Italy: A Real-World Study Linking Administrative and Pathology Data
    Carmen Criscitiello, Valentina Perrone, Luca Degli Esposti +4
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  14. Short-Term Surgical Outcomes and Postoperative Safety in Octogenarian Patients Undergoing Colorectal Cancer Resection: A Comparative Cohort Study
    Albert Garcia-Nalda, Victor Admella-Clanchet, Anna Serracant-Barrera +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  15. Error in Number of Cancers
    JAMA Network OpenPeer-reviewedCC BY 4.0OncologyCrossref
  16. GLP-1 RA Prescribing in Patients With Type 2 Diabetes and Cancer
    Xin Hu, Changchuan Jiang, Xuesong Han +8
    JAMA Network OpenPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossrefPMC
  17. Immune synapse in the tumor microenvironment: functional dynamics and clinical translational perspectives
    Yujie Ge, Senxu Lu, Bingqian He +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  18. Case Series: Severe cholangitis as an immune checkpoint inhibitor induced adverse event in four cases: management and treatment options including tocilizumab and ursodeoxycholic acid
    Darina Kohoutova, Joshua Shur, Monica Terlizzo +17
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  19. Impaired ex vivo T-cell expansion before leukapheresis is associated with out-of-specification tisagenlecleucel manufacturing in pediatric CD19+ALL
    Melanie Bremm, Greta Heinze, Lara Schneeberger +15
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  20. Fractalkine produced by Shiga toxin type 2-stimulated human glomerular endothelial cells modulates γδ T lymphocyte migration
    David Antonio Rosso, Micaela Rosato, Martín Ledesma +6
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  21. The glutamine-aspartate metabolic tradeoff between fast growth and metabolic flexibility
    Karin Ortmayr, Meret Ringwald, Laurentz Schuhknecht +8
    Genome BiologyPeer-reviewedCC BY 4.0OncologyCrossref
  22. Mechanisms of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Martina Milella, Francesco Lasorsa, Monica Rutigliano +5
    CellsPeer-reviewedCC BY 4.0OncologyCrossref
  23. Mechanosensitive Non-Coding RNAs in Cardiovascular Disease: Mechanisms, Therapeutic Targeting and Cardiac Delivery
    Irene Fancello, Veronica Candino, Daniel Gamo Gonzalez +2
    CellsPeer-reviewedCC BY 4.0OncologyCrossref
  24. High Intratumoral PROS1 Expression Is Associated with Improved Survival, Reduced Hypoxia Score Markers, and Alterations in Gene Expression Associated with Oncogene Signaling and Cell Cycle Signaling in Selected Solid Tumors
    Teagan Prouse, Rinku Majumder, Samarpan Majumder
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  25. Early Toxicities of CAR-T Cell Therapy: Mechanisms, Prediction, and Management
    Swathi Srikantan, Alexander Weiss, Zainab Muslehuddin +1
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref